CNC Investors Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit with the Schall Law Firm
Investors who purchased the Company's securities between December 12, 2024 and June 30, 2025, inclusive (the 'Class Period'), are encouraged to contact the firm before September 8, 2025.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Centene created the false impression that it could accurately forecast its projected growth and revenue outlook. The Company also touted strong enrollment rates and low morbidity. The Company's optimistic guidance was shattered by an analysis that showed lower-than-expected enrollment and increased aggregate market morbidity. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Centene, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
29 minutes ago
- Globe and Mail
College Counseling Firm, Prepory, Ranks on the 2025 Inc. 5000 List of America's Fastest-Growing Private Companies
Miami, Florida--(Newsfile Corp. - August 13, 2025) - Prepory, the Miami-based college admissions coaching company reimagining how students prepare for college, has been named to the 2025 Inc. 5000 list, Inc. Magazine's annual ranking of the fastest-growing private companies in America. To view an enhanced version of this graphic, please visit: With significant revenue growth over the last three years, Prepory joins a list that has included household names like Microsoft, Meta, and Patagonia, underscoring its rise as a leader in student-first education services. "When we started Prepory in a college dorm room, we weren't dreaming of Inc. 5000. We were imagining a world where college admissions didn't have to be so hard," said Daniel Santos, CEO and co-founder."This honor is a testament to the students who trusted us, the families who believed in us, and the team that brought it all to life." Unlike traditional firms that focus on prestige and pressure, Prepory combines admissions strategy with coaching rooted in emotional intelligence and authenticity. Its team has supported more than 14,000 students across 40+ countries, helping them lead with purpose, not just polish. This recognition follows the launch of Rory, Prepory's new AI-powered admissions assistant. Designed to make expert coaching more scalable and affordable, Rory offers 24/7 guidance powered by Prepory's proven approach. "We believe great college advising blends people and technology," added Santos. "Rory helps us do both, without sacrificing care or quality." About the 2025 Inc. 5000 List The 2025 Inc. 5000 honorees have demonstrated remarkable growth amid rising costs and market uncertainty. For the full list, visit About Prepory Prepory is a global college admissions and career coaching company serving families, schools, and nonprofits in 40+ countries. Its students have gained admission to top institutions including Harvard, Yale, and Stanford. Learn more at
Globe and Mail
an hour ago
- Globe and Mail
TROX Investors Have Opportunity to Join Tronox Holdings plc Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tronox Holdings plc ('Tronox' or 'the Company') (NYSE: TROX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Tronox reported its Q2 2025 financial results on July 30, 2025. The Company reported a 10.9% year-over-year decline in revenues, missing consensus estimates. The Company claimed that "delays in Brazil's anti-dumping investigation impacted our sales in the region." Based on this news, shares of Tronox fell by more than 37.9% on the next day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Globe and Mail
an hour ago
- Globe and Mail
Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Tandem Diabetes Care, Inc. ('Tandem' or the 'Company') (NASDAQ: TNDM) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TANDEM DIABETES CARE, INC. (TNDM), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On August 7, 2025, Tandem disclosed that a malfunction had been identified in some of its insulin pumps which could 'trigger an error resulting in a discontinuation of insulin delivery' which 'could result in hyperglycemia due to discontinuation of insulin delivery' and 'may require hospitalization or intervention from a medical professional.' The Company stated that it had sent notices to impacted customers between July 22 and 24, 2025. On this news, Tandem's stock price fell $2.87, or 19.9%, to close at $11.52 per share on August 7, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you purchased Tandem securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Call us at: 310-914-5007 Email us at: info@ Visit our website at: Follow us for updates on Twitter at This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
